3D printing in medicine /

Mostrar otras versiones (1)

3D Printing in Medicine, Second Edition examines the rapidly growing market of 3D-printed biomaterials and their clinical applications. With a particular focus on both commercial and premarket tools, the book looks at their applications within medicine and the future outlook for the field. The chapt...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Kalaskar, Deepak M. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge, MA ; Kidlington, United Kingdom Woodhead Publishing, [2023]
Edición:Second edition.
Colección:Woodhead Publishing series in biomaterials.
Temas:
Biomedical materials > Design.
Biomedical materials > Technological innovations.
Three-dimensional printing.
Printing, Three-Dimensional
Biomat�eriaux > Innovations.
Impression tridimensionnelle.
3-D printing.
Three-dimensional printing
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • 3D Printing in Medicine
  • Copyright Page
  • Contents
  • List of contributors
  • Preface
  • 1 Introduction to three-dimensional printing in medicine
  • 1.1 3D printing is the latest industrial revolution
  • 1.1.1 Brief history of 3D printing
  • 1.1.2 Basic components of 3D printing
  • 1.2 3D bioprinting in medicine
  • 1.2.1 3D bioprinting approaches
  • 1.2.1.1 Biomimicry
  • 1.2.1.2 Independent self-assembly
  • 1.2.1.3 Miniature-tissue blocks
  • 1.2.2 Feasibility of organ printing technology
  • 1.2.3 In vivo behavior of 3D printed organ constructs
  • 1.3 Advantages of 3D printing for medicine
  • 1.3.1 Applications of 3D printing in medicine
  • 1.3.1.1 3D printing for surgical templates and diagnostic tools
  • 1.3.1.2 Organ printing technology
  • 1.3.1.3 3D disease modeling
  • 1.3.1.4 3D printing for commercial pharmaceutical products
  • 1.3.1.5 4D bioprinting
  • 1.3.2 Limitations and challenges of 3D printing
  • 1.4 Future of 3D printing in medicine
  • 1.5 Regulation, intellectual property, ethics and standards for 3D printing in medicine
  • 1.5.1 Commercial 3D bioprinters
  • 1.5.2 International standards and regulatory framework of 3D bioprinting
  • 1.5.2.1 International standards used for 3D bioprinting
  • 1.5.2.2 Regulatory authorities and guidelines
  • 1.5.3 Intellectual property and socio-ethical implications of organ 3D printing
  • 1.5.3.1 Intellectual property in 3D bioprinting
  • 1.5.3.2 Ethics and social concerns of organs on demand
  • References
  • 2 3D printing families: laser, powder, and nozzle-based techniques
  • 2.1 Introduction
  • 2.2 Classification of 3D printing techniques
  • 2.2.1 Resin-based systems
  • 2.2.2 Powder-based systems
  • 2.2.3 Extrusion-based systems
  • 2.2.4 Droplet-based systems
  • 2.3 Challenges and Food and Drug Administration regulations
  • 2.4 Conclusions and future trends
  • Acknowledgments.
  • 4.4.3 Enriching the knowledge of cardiovascular biomechanics with combination of computational and 3D printed models
  • 4.4.4 Planning procedures
  • 4.5 Patient-specific models: the current perspective of regulatory bodies and policy makers
  • 4.6 Future perspective of patient-specific models in cardiovascular applications
  • References
  • 5 3D printers for surgical practice
  • 5.1 Introduction
  • 5.2 Imaging to printed model: steps involved
  • 5.3 Limitations of CT and MRI images for surgical planning
  • 5.4 3D printed models for anatomical simulation for surgeons
  • 5.4.1 Orthopedic tissues
  • 5.4.2 Cardiac surgery: heart valve surgery
  • 5.4.3 Neurosurgery
  • 5.4.4 Malignant tissues
  • 5.5 Surgical planning of congenital anomalies
  • 5.6 3D printed models for anatomical teaching
  • 5.7 Tissue defect-specific implant design
  • 5.8 3D printing for surgical templates and diagnostic tools
  • 5.9 Advantages of 3D printed models
  • 5.10 Challenges for 3D printed models
  • 5.11 Legal and ethical issues for 3D printing in surgery
  • 5.12 Conclusion
  • References
  • 6 Patient-specific 3D bioprinting for in situ tissue engineering and regenerative medicine
  • 6.1 Patient-specific 3D printing
  • 6.1.1 Personalized medicine
  • 6.1.2 Introduction to 3D printing technology: 3D printing in personalized medicine
  • 6.1.3 Patient-specific 3D model creation and application of machine learning and artificial intelligence algorithms
  • 6.2 Current medical applications for 3D printing
  • 6.2.1 3D bioprinting of vascularized organs and tissues in vitro
  • 6.2.2 3D bioprinting of organs for personalized drug screening and disease modeling
  • 6.2.3 In situ 3D bioprinting directly to the defect/wound site
  • 6.2.3.1 Wound repair
  • 6.2.3.2 Bone defect repair
  • 6.3 Challenges and future advancements
  • 6.4 Summary
  • References
  • 7 3D-bioprinted in vitro disease models.
  • 7.1 Introduction
  • 7.2 Bioinks
  • 7.3 3D disease modeling
  • 7.3.1 Cancer modeling
  • 7.3.2 Tissues models and new therapies screening
  • 7.3.2.1 3D printed osteoarthritis models
  • 7.4 Concluding remarks and future prospects
  • Acknowledgments
  • References
  • 8 3D printed pharmaceutical products
  • 8.1 Introduction
  • 8.2 Pharmaceutical 3D printing
  • 8.2.1 Material extrusion
  • 8.2.1.1 Fused filament fabrication
  • Benefits
  • Challenges and solutions
  • 8.2.1.2 Pneumatic extrusion
  • Benefits
  • Challenges and solutions
  • 8.2.2 Vat-based 3D printing
  • 8.2.2.1 Benefits
  • 8.2.2.2 Challenges and solutions
  • 8.2.3 Powder bed fusion: selective laser sintering
  • 8.2.3.1 Benefits, challenges and solutions
  • 8.2.4 Inkjet-based 3D printing
  • 8.2.4.1 Benefits, challenges and solutions
  • 8.3 Active pharmaceutical ingredients synthesis and assessment using 3D printing
  • 8.4 Conclusions
  • References
  • 9 High-resolution 3D printing for healthcare
  • 9.1 Clinical need and context
  • 9.2 High-resolution 3D printing
  • 9.3 Types of high-resolution 3D printing
  • 9.3.1 Direct-write printing
  • 9.3.2 Electrohydrodynamic printing
  • 9.3.3 3D direct laser writing
  • 9.3.4 Focused ion beam
  • 9.3.5 Digital light process and two-photon photolithography
  • 9.4 Fundamentals of micro/nanofluidics
  • 9.4.1 Micro/nanofluidics
  • 9.4.2 Ink properties: preliminary aspects of rheology
  • 9.4.3 Viscoelasticity
  • 9.4.4 Wetting
  • 9.4.5 Evaporation
  • 9.4.6 Dynamic effects
  • 9.5 Printing materials
  • 9.5.1 Nonbiologic printing materials
  • 9.5.2 Bioink printing
  • 9.6 Exemplar functional devices
  • 9.6.1 Interconnects
  • 9.6.2 Site-specific deposition
  • 9.6.3 Healthcare sensors
  • 9.6.4 Implantable devices
  • 9.6.5 Printed bioscaffolds
  • 9.6.6 Mechanobiology and cell signaling studies
  • 9.6.7 Biomedical microrobots
  • 9.7 Conclusions and future direcions.

Ejemplares similares